| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
President and CFO | President and CFO
1 company
Andrew Guggenhime is President and CFO at PCVX. From November 2021 to September 2026, the filings on record show 0 open-market purchases and 32 sales. Andrew Guggenhime's net worth is not public. Form 4 filings only show shares in the companies where this person is an insider; those holdings are worth an estimated $5.8M at current prices.
Our model assigns Andrew Guggenhime a below-average insider score of 46/100, based on 33 past trades. Over a 12-month horizon, 35.5% of those trades were profitable, with an average 12-month return of -27.5%.
The PCVX filings lean toward selling, a net 284,100 shares.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct 18, 2023 | PCVX Vaxcyte, Inc. | President and CFO | Sale+OE10b5-1 | 8,000 | $45.91 | $367,300.31 | -9.1% | +34.2% | +151.2% | |
| Sep 19, 2022 | PCVX Vaxcyte, Inc. | President and CFO | Sale+OE | 3,100 | $26.10 | $80,897.88 | -7.6% | +64.8% | +93.0% | |
| Aug 29, 2022 | PCVX Vaxcyte, Inc. | President and CFO | Sale+OE | 36,000 | $28.00 | $1,008,000.00 | -46.0% | +57.8% | +85.7% | |
| Aug 18, 2022 | PCVX Vaxcyte, Inc. | President and CFO | Sale+OE | 3,100 | $25.26 | $78,320.24 | -6.8% | +65.7% | +90.4% | |
| Jul 18, 2022 | PCVX Vaxcyte, Inc. | President and CFO | Sale+OE | 3,100 | $24.53 | $76,047.23 | -6.8% | +7.9% | +94.7% | |
| Jul 8, 2022 | PCVX Vaxcyte, Inc. | President and CFO | Sale+OE | 3,100 | $24.00 | $74,400.00 | -6.8% | -1.8% | +95.3% | |
| May 18, 2022 | PCVX Vaxcyte, Inc. | President and CFO | Sale+OE | 3,100 | $24.44 | $75,762.80 | -6.8% | +5.8% | +102.4% | |
| Apr 18, 2022 | PCVX Vaxcyte, Inc. | President and CFO | Sale+OE | 3,100 | $24.05 | $74,542.29 | -7.1% | +1.7% | +87.0% | |
| Mar 18, 2022 | PCVX Vaxcyte, Inc. | President and CFO | Sale+OE | 3,100 | $26.13 | $80,992.77 | -7.1% | -27.9% | +44.6% | |
| Mar 1, 2022 | PCVX Vaxcyte, Inc. | President and CFO | Sale+OE | 6,200 | $24.00 | $148,800.00 | -66.5% | +0.6% | +74.8% |